Millennium Management
KYTH

Millennium Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Millennium Management’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-50,000
Closed -$1.73M – 4477
2014
Q4 		$1.73M Buy
+50,000
New +$1.74M ﹤0.01% 2090

Other funds holding KYTH

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Millennium Management's KYTH Position: Q2 2015 in Review

Millennium Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q2 2015, closing a stake of 140,345 shares — an estimated $7.52M sold.

Millennium Management first reported a position in KYTH in Q2 2013 and held it in 7 quarters. The position peaked at $9.05M in Q4 2013. 153 funds tracked by Wall St. Rank hold KYTH as of Q2 2015.

  • Millennium Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q2 2015 after selling out during the quarter.
  • Millennium Management sold 140,345 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q2 2015, an estimated $7.52M.
  • Millennium Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 7 quarters.
  • Millennium Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $9.05M in Q4 2013.
  • 153 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q2 2015.

Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.